Determination of SR 49059 in human plasma and urine by LC-APCI/MS/MS

This publication has 8 references indexed in Scilit:

• The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the Class III antiarrhythmic agent, MK-0499, in human plasma and urine
  Journal of Pharmaceutical and Biomedical Analysis, 1995
• Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1994
• A rapid and specific assay, based on liquid chromatography—atmospheric pressure chemical ionization mass spectrometry, for the determination of MK-434 (a 5α-reductase inhibitor) and its metabolites in plasma
  Journal of Pharmaceutical and Biomedical Analysis, 1994
• Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
  Journal of Clinical Investigation, 1993
• The sensitive determination of abanoquil in blood by high-performance liquid chromatography/atmospheric pressure ionization mass spectrometry
  Journal of Mass Spectrometry, 1992
• Simultaneous determination of tenidap and its stable isotope analog in serum by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry
  Journal of Mass Spectrometry, 1992
• Determination of L-654,066, a new 5α-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry
  Journal of Mass Spectrometry, 1992
• Quantitative analysis by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry: The determination of the renin inhibitor CP-80,794 in human serum
  Journal of the American Society for Mass Spectrometry, 1991